Persium Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$378K Buy
327
+17
+5% +$20.1K 0.2% 56
2026
Q2
$372K Sell
310
-5
-2% -$5.11K 0.24% 57
2026
Q1
$290K Sell
315
-25
-7% -$25.3K 0.23% 52
2025
Q4
$365K Buy
+340
New +$325K 0.26% 51

Other funds holding LLY

Persium Advisors's LLY Position: Q3 2026 in Review

Persium Advisors increased its Eli Lilly (LLY) stake by 5.5% in Q3 2026, buying an estimated $20.1K and bringing the position to 327 shares worth $378K. The position accounts for 0.2% of the portfolio, ranked #56.

Persium Advisors first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. 987 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Persium Advisors held 327 shares of Eli Lilly worth $378K as of Q3 2026.
  • Persium Advisors bought 17 Eli Lilly shares in Q3 2026, an estimated $20.1K.
  • Eli Lilly made up 0.2% of Persium Advisors's portfolio in Q3 2026, its #56 holding.
  • Persium Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • 987 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Persium Advisors's 13F filing for Q3 2026, filed 7 Oct 2026.